Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

Share Price is delayed by 15 minutes
Get Live Data
65.50    -5.00 (-7.09%)
Bid:
65.00
Ask:
68.00
Spread: 3.00 (4.615%)
Market Cap: £52.41m
HDD Live PriceLast checked at - London Stock Exchange

Intraday Hardide Share Chart

Placing of Shares

26 May 2006 07:01

Hardide PLC26 May 2006 Press Release 26 May 2006 Hardide Plc ("Hardide" or "the Company") Placing of Shares Hardide Plc (AIM:HDD), the provider of unique surface engineering technologyannounces that it has conditionally raised £1.55 million (before expenses) forthe Company via a placing for cash of 12,386,832 Ordinary Shares of 1 pence each("Ordinary Shares") at 12.5 pence per share ("the Placing"). In addition,601,650 Ordinary Shares held by Dr Yuri Zhuk, Technical Director of Hardide, and8,598,350 Ordinary Shares held by Flintstone Management Services Limited ("FMS"), a subsidiary of Proventec PLC, have also been placed at the placingprice with institutional and other investors. The net receivable proceeds of the Placing will be used to fund the Company'scontinuing expansion. Mr David Chestnutt, non-executive Chairman of Hardide, is also a director ofFMS. FMS has undertaken not to dispose of any further Ordinary Shares withoutthe permission of the Company's broker, Daniel Stewart & Co plc, before 30November 2006. Application has been made for the admission of the 12,386,832 Ordinary Sharessubject to the Placing to be admitted to trading on AIM ("Admission"). It isexpected that Admission will take place on 1 June 2006. At Admission, theCompany will have 146,742,236 Ordinary Shares in issue. Jim Murray-Smith, Chief Executive of the Company, has subscribed for 200,000Ordinary Shares in the Placing. Following Admission, Mr Murray-Smith will havean interest in 428,000 Ordinary Shares, representing 0.27% of the issued sharecapital. Following Admission, Dr Zhuk will have a residual interest in 4,364,465 OrdinaryShares, representing 2.97% of the issued share capital. Following Admission, FMS will have a residual interest in 31,499,725 OrdinaryShares, representing 21.47% of the issued share capital. Commenting on the Placing, Jim Murray-Smith, Chief Executive of Hardide Plc,said: "The proceeds from the Placing will enable the Company to strengthen thesenior management team, underpin and accelerate expansion in the US. Initialindications from the US oil, gas and pump markets continue to suggest extremelyhigh demand for Hardide's unique products. The opening of our new manufacturingfacility in Houston is still on schedule for October 2006. We have been particularly encouraged by the strong demand from both existing andnew institutional investors and look forward to sharing Hardide's future successwith them. The Board remains confident of meeting market expectations for thefull year." For further information: Hardide plc Jim Murray Smith, Chief Executive Tel: +44 (0) 1869 353 830 jmurray-smith@hardide.com www.hardide.com Daniel Stewart & Company plc Paul Shackleton, Corporate Finance Tel: +44 (0) 20 7776 6550 www.danielstewart.co.uk Media enquiries: Abchurch Chris Lane / Katherine Murphy Tel: +44 (0) 20 7398 7700 chris.lane@abchurch-group.com www.abchurch-group.com Notes to editors Hardide provides and applies tungsten carbide coatings to a wide range ofengineering components. The Company's patented technology is unique in that itcombines both abrasion and corrosion resistant properties in one coating. Whenapplied to components, the technology is proven to offer dramatic cost savingsthrough reduced downtime and extended component life. Customers include leadingcompanies operating in oil and gas exploration and production, valve and pumpsmanufacturing and general engineering. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Mar 20243:02 pmRNSBoard Update
5th Mar 20241:33 pmRNSHolding(s) in Company
5th Mar 202410:30 amRNSHolding(s) in Company
26th Feb 20242:04 pmRNSHolding(s) in Company
23rd Feb 202412:33 pmRNSHolding(s) in Company
21st Feb 20246:00 pmRNSResult of Fundraising
21st Feb 20244:35 pmRNSProposed equity fundraising
21st Feb 20244:30 pmRNSAudited Annual Report and Notice of AGM
8th Feb 20247:00 amRNSInterim CEO appointment
8th Feb 20247:00 amRNSPreliminary FY23 results & FY24 trading update
1st Nov 20237:00 amRNSBoard Changes
18th Oct 20237:00 amRNSYear End Trading Update
21st Jul 20239:02 amRNSHolding(s) in Company
26th May 20231:46 pmRNSDirector/PDMR Shareholding
17th May 20237:00 amRNSInterim Results
10th May 20237:00 amRNSHardide Coatings partners with Gardner Aerospace
23rd Mar 202312:18 pmRNSHolding(s) in Company
23rd Mar 202311:36 amRNSResult of AGM
23rd Mar 20237:00 amRNSAGM Statement
22nd Feb 20234:33 pmRNSPosting of Annual Report and Notice of AGM
8th Feb 20237:00 amRNSAnnual results for year ended 30 September 2022
25th Jan 20237:00 amRNSBoard Update
22nd Dec 20227:00 amRNSFunding and Annual Results Update
15th Nov 20228:16 amRNSHolding(s) in Company
27th Oct 20227:00 amRNSSupplier Approval & Order for Leonardo Helicopters
24th Oct 20223:00 pmRNSDirectorate Changes
13th Oct 20227:00 amRNSYear End Trading Update
9th Sep 202211:45 amRNSResult of Fundraising
9th Sep 20227:00 amRNSProposed equity fundraising
14th Jul 20227:00 amRNSTrading update
10th May 20227:00 amRNSResignation of Non-Executive Chairman
10th May 20227:00 amRNSInterim Results
5th Apr 20221:53 pmRNSHolding(s) in Company
22nd Mar 20228:37 amRNSHolding(s) in Company
11th Mar 202212:37 pmRNSResult of AGM
11th Mar 20227:00 amRNSAGM Statement
1st Mar 20227:00 amRNSContract Award
15th Feb 20224:15 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSPreliminary results
19th Oct 20217:00 amRNSHolding(s) in Company
7th Oct 20219:05 amRNSSecond Price Monitoring Extn
7th Oct 20219:00 amRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSYear End Trading Update
9th Sep 20212:05 pmRNSSecond Price Monitoring Extn
9th Sep 20212:00 pmRNSPrice Monitoring Extension
9th Sep 20217:00 amRNSContract Award
14th Jul 20218:17 amRNSHolding(s) in Company
6th Jul 20217:00 amRNSNew Facility Receives Airbus Approval
5th Jul 20213:46 pmRNSHolding(s) in Company
7th Jun 202111:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.